ADAR1 Capital Management »

Athira Pharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Athira Pharma shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 394k 7.34

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Athira Pharma

Perceptive Advisors
TCG Crossover Management
Commodore Capital
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors
Geode Capital Management
Susquehanna International

View all funds holding Athira Pharma